Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.33SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.62SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.391SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.448SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DV.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2 (Omicron)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
CH.1.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
BA.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.2.75.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
BQ.1.1.66SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BN.1.3.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.2.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
JN.3.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
JN.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
GE.1.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-17071Singapore
JN.1.58.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
JN.1.8.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-12905.4Singapore
KP.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
JN.1.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
XDD.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13206.2Singapore
XDNSYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.5.2.20SYoung-STATACATGTCTCTGGGACCA20452176321782F29.6049Singapore
BQ.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
DV.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.4.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BN.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.5.1.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.2.75SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.5 (Omicron)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
CH.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
BA.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
BA.5.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.5.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.2.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BE.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BN.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BF.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.5.2.44SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BN.1.3.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BQ.1.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
LT.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.8.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13103.9Singapore
LV.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used